ArticleScientific reports2025

Pyrazolopyridine pyrimidone hybrids as potential DprE1 inhibitors, design, synthesis and biological evaluation as antitubercular agents.

Moksh Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.